CYTOGENETICS AND LONG-TERM SURVIVAL IN MM-003, A PHASE 3 TRIAL OF POMALIDOMIDE plus LOW-DOSE DEXAMETHASONE VS. HIGH-DOSE DEXAMETHASONE IN REFRACTORY OR RELAPSED AND REFRACTORY MULTIPLE MYELOMA

被引：0

作者：

Dimopoulos, M. A. ^{[1
]}

Weisel, K. ^{[2
]}

Song, K. W. ^{[3
]}

Delforge, M. ^{[4
]}

Karlin, L. ^{[5
]}

Goldschmidt, H. ^{[6
,7
]}

Moreau, P. ^{[8
]}

Banos, A. ^{[9
]}

Oriol, A. ^{[10
]}

Garderet, L. ^{[11
]}

Cavo, M. ^{[12
]}

Ivanova, V. ^{[13
]}

Alegre, A. ^{[14
]}

Martinez-Lopez, J. ^{[15
]}

Chen, C. I. ^{[16
]}

Spencer, A. ^{[17
]}

Knop, S. ^{[18
]}

Bahlis, N. J. ^{[19
]}

Renner, C. ^{[20
]}

Yu, X. ^{[21
]}

Hong, K. ^{[21
]}

Sternas, L. ^{[21
]}

Jacques, C. ^{[21
]}

Zaki, M. H. ^{[21
]}

San Miguel, J. F. ^{[22
]}

机构：

[1] Univ Athens, Sch Med, Alexandra Hosp, GR-11527 Athens, Greece

[2] Univ Tubingen, Dept Hematol & Oncol, Tubingen, Germany

[3] Vancouver Gen Hosp, Vancouver, BC, Canada

[4] Univ Hosp Leuven, Leuven, Belgium

[5] Hosp Civils Lyon, Ctr Hosp Lyon Sud, Pierre Benite, France

[6] Univ Heidelberg Hosp, Heidelberg, Germany

[7] German Canc Res Ctr, Heidelberg, Germany

[8] Univ Hosp Hotel Dieu, Hematol Dept, Nantes, France

[9] Ctr Hosp Cote Basque, Bayonne, France

[10] HGTiP, Catala Oncol, Barcelona, Spain

[11] Hop St Antoine, F-75571 Paris, France

[12] Univ Bologna, Sch Med, Seragnoli Inst Hematol, Bologna, Italy

[13] GUZ Moscow City Clin Hosp SP Botkin, Moscow, Russia

[14] Hosp Univ Princesa, Madrid, Spain

[15] Hosp Univ 12 Octubre, Madrid, Spain

[16] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada

[17] Monash Univ, Alfred Hosp, Melbourne, Vic 3181, Australia

[18] Univ Wurzburg, Med Ctr, D-97070 Wurzburg, Germany

[19] Univ Calgary, Calgary, AB, Canada

[20] Univ Zurich Hosp, Oncol Dept, CH-8091 Zurich, Switzerland

[21] Celgene Corp, Summit, NJ USA

[22] Univ Navarra, E-31080 Pamplona, Spain

来源：

HAEMATOLOGICA | 2014年 / 99卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

P966

引用

页码：365 / 365

页数：1

共 50 条

[1] OVERALL SURVIVAL OF PATIENTS WITH RELAPSED AND REFRACTORY MULTIPLE MYELOMA: ADJUSTING FOR CROSSOVER IN THE MM-003 TRIAL FOR POMALIDOMIDE PLUS LOW-DOSE DEXAMETHASONE VS. HIGH-DOSE DEXAMETHASONE
Morgan, G.
San Miguel, J. F.
Dhanasiri, S.
Lee, D.
Palumbo, A.
Facon, T.
Zaki, M.
Yu, X.
Sternas, L.
Jacques, C.
Weisel, K.
Offner, F.
Dimopoulos, M.
[J]. HAEMATOLOGICA, 2014, 99 : 365 - 366
[2] MM-003, A PHASE 3 STUDY OF POMALIDOMIDE plus LOW-DOSE DEXAMETHASONE VS. HIGH-DOSE DEXAMETHASONE IN REFRACTORY OR RELAPSED AND REFRACTORY MULTIPLE MYELOMA: OUTCOMES BY PRIOR THERAPY AND RESPONSE DEPTH
San Miguel, J. F.
Weisel, K. C.
Song, K. W.
Delforge, M.
Karlin, L.
Goldschmidt, H.
Moreau, P.
Banos, A.
Oriol, A.
Garderet, L.
Cavo, M.
Ivanova, V.
Alegre, A.
Martinez-Lopez, J.
Chen, C. I.
Renner, C.
Bahlis, N. Jacques
Yu, X.
Teasdale, T.
Sternas, L.
Jacques, C.
Zaki, M. H.
Dimopoulos, M. A.
[J]. HAEMATOLOGICA, 2014, 99 : 110 - 110
[3] Pomalidomide plus low-dose dexamethasone (POM plus LoDEX) versus high-dose dexamethasone (HiDEX) in relapsed/refractory multiple myeloma (RRMM): Impact of cytogenetics in MM-003
Goldschmidt, Hartmut
Dimopoulos, Meletios A.
Weisel, Katja C.
Moreau, Philippe
Lacy, Martha
Song, Kevin W.
Delforge, Michel
Karlin, Lionel
Banos, Anne
Rocafiguera, Albert Oriol
Yu, Xin
Sternas, Lars
Jacques, Christian
Zaki, Mohamed H.
San-Miguel, Jesus F.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
[4] Analysis of renal impairment in MM-003, a phase III study of pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone in refractory or relapsed and refractory multiple myeloma
Weisel, Katja C.
Dimopoulos, Meletios A.
Moreau, Philippe
Lacy, Martha Q.
Song, Kevin W.
Delforge, Michel
Karlin, Lionel
Goldschmidt, Hartmut
Banos, Anne
Oriol, Albert
Alegre, Adrian
Chen, Christine
Cavo, Michele
Garderet, Laurent
Ivanova, Valentina
Martinez-Lopez, Joaquin
Knop, Stefan
Yu, Xin
Hong, Kevin
Sternas, Lars
Jacques, Christian
Zaki, Mohamed H.
Miguel, Jesus San
[J]. HAEMATOLOGICA, 2016, 101 (07) : 872 - 878
[5] Final Analysis, Cytogenetics, Long-Term Treatment, and Long-Term Survival In MM-003, A Phase 3 Study Comparing Pomalidomide plus Low-Dose Dexamethasone (POM plus LoDEX) Vs High-Dose Dexamethasone (HiDEX) In Relapsed/Refractory Multiple Myeloma (RRMM)
Dimopoulos, Meletios A.
Weisel, Katja
Song, Kevin W.
Delforge, Michel
Karlin, Lionel
Goldschmidt, Hartmut
Moreau, Philippe
Banos, Anne
Oriol, Albert
Garderet, Laurent
Cavo, Michele
Ivanova, Valentina
Alegre, Adrian
Lopez, Joaquin Martinez
Chen, Christine I.
Spencer, Andrew
Knop, Stefan
Bahlis, Nizar J.
Renner, Christoph
Yu, Xin
Hong, Kevin
Sternas, Lars
Jacques, Christian
Zaki, Mohamed H.
San Miguel, Jesus F.
[J]. BLOOD, 2013, 122 (21)
[6] ADVERSE EVENTS AND MANAGEMENT IN MM-003, A PHASE 3 STUDY OF POMALIDOMIDE plus LOW-DOSE DEXAMETHASONE (POM plus LODEX) VS. HIGH-DOSE DEXAMETHASONE (HIDEX) IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)
Delforge, M.
Dimopoulos, M.
Weisel, K.
Moreau, P.
Lacy, M.
Song, K.
Karlin, L.
Goldschmidt, H.
Banos, A.
Oriol, A.
Alegre, A.
Chen, C.
Cavo, M.
Garderet, L.
Ivanova, V.
Martinez-Lopez, J.
Yu, X.
Sternas, L.
Jacques, C.
Zaki, M.
Miguel, J.
[J]. HAEMATOLOGICA, 2013, 98 : 329 - 330
[7] Pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone for patients with relapsed and refractory multiple myeloma (MM-003): a randomised, open-label, phase 3 trial
San Miguel, Jesus
Weisel, Katja
Moreau, Philippe
Lacy, Martha
Song, Kevin
Delforge, Michel
Karlin, Lionel
Goldschmidt, Hartmut
Banos, Anne
Oriol, Albert
Alegre, Adrian
Chen, Christine
Cavo, Michele
Garderet, Laurent
Ivanova, Valentina
Martinez-Lopez, Joaquin
Belch, Andrew
Palumbo, Antonio
Schey, Stephen
Sonneveld, Pieter
Yu, Xin
Sternas, Lars
Jacques, Christian
Zaki, Mohamed
Dimopoulos, Meletios
[J]. LANCET ONCOLOGY, 2013, 14 (11): : 1055 - 1066
[8] Health-related quality of life from the MM-003 trial of pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone in relapsed and/or refractory multiple myeloma
Song, Kevin W.
Dimopoulos, Meletios A.
Weisel, Katja C.
Moreau, Philippe
Palumbo, Antonio
Belch, Andrew
Schey, Stephen
Sonneveld, Pieter
Sternas, Lars
Yu, Xin
Amatya, Ramesh
Monzini, Mara S.
Zaki, Mohamed
Jacques, Christian
Miguel, Jesus San
[J]. HAEMATOLOGICA, 2015, 100 (02) : E63 - E67
[9] IMPACT OF STABLE DISEASE AS A RESPONSE TO POMALIDOMIDE PLUS LOW-DOSE DEXAMETHASONE ON SURVIVAL OUTCOMES IN PATIENTS WITH REFRACTORY OR RELAPSED AND REFRACTORY MULTIPLE MYELOMA IN THE MM-003 TRIAL
Moreau, P.
Weisel, K.
Song, K.
Gibson, C.
Saunders, O.
Sternas, L.
Hong, K.
Zaki, K.
Dimopoulos, M. A.
[J]. HAEMATOLOGICA, 2015, 100 : 312 - 312
[10] Overall survival of relapsed and refractory multiple myeloma patients after adjusting for crossover in the MM-003 trial for pomalidomide plus low-dose dexamethasone
Morgan, Gareth
Palumbo, Antonio
Dhanasiri, Sujith
Lee, Dawn
Weisel, Katja
Facon, Thierry
Delforge, Michel
Oriol, Albert
Zaki, Mohamed
Yu, Xin
Sternas, Lars
Jacques, Christian
Akehurst, Ron
Offner, Fritz
Dimopoulos, Meletios A.
[J]. BRITISH JOURNAL OF HAEMATOLOGY, 2015, 168 (06) : 820 - 823

← 1 2 3 4 5 →